Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Discov Today. 2003 Aug 1;8(15):681-91.

Medicinal chemistry of target family-directed masterkeys.

Author information

  • 1Axxima Pharmaceuticals AG, Max-Lebsche-Platz 32, 81377 Münich, Germany. gerhard.mueller@axxima.com

Abstract

The majority of pharmaceutically relevant drug targets cluster into densely populated target families, thus offering a novel approach that complements the currently favoured screening paradigm in medicinal chemistry. This approach uses a privileged structure concept whereby molecular masterkeys are developed that account for a target family wide structural or functional commonality. Numerous lead compounds, based on multipurpose privileged structures, can be generated that address a variety of targets from a gene family of interest, irrespective of therapeutic area. Several different interpretations of the privileged structure concept will be highlighted, with a strong emphasis on the most stringent application: the optimization of a molecular masterkey for a distinct target family of interest.

PMID:
12927511
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk